Rivastigmine
Application
Treatment of Dementia Associated with mild, moderate or severe alzheimer’s disease
| Available in 3 strengths | |
|---|---|
| 5mg / 24 hr | |
| 10mg / 24hr | |
| 15mg / 24hr | |
| Packing | Peelable pouch- 1 Patch/Pouch |
| Shelf Life | 36 months |
| Duration of action | 24 hours |
| Regulatory status | Approved in India |